Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Clinical trial NCT05012254 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05012254
Sponsor: Fundación GECP
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Brain Metastases, Adult Lung Cancer

Start date: 2021-11-18
Primary completion: 2027-10-15
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.